EPIX Pharmaceuticals To Present Phase 2a Alzheimer’s Data At Keystone Symposia

EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, announced that Tom Megerian, M.D., Ph.

More: continued here

Filed under: Alzheimer's / Dementia News XML/RSS Feed on April 2nd, 2008